Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03) - Abstract

Department of Radiation Oncology, Royal Prince Alfred Hospital, Camperdown, Australia.


Randomised controlled trials (RCTs) can be hampered by poor patient accrual and retention. Decision aids (DAs) containing simple, evidence-based information, may assist patients with decision-making regarding trial participation. The current DA was of use for 95% of participants. Further evaluation of the DA in a RCT is currently underway.

Written by:
Sundaresan P, Turner S, Kneebone A, Pearse M, Butow P.   Are you the author?

Reference: Radiother Oncol. 2011 Oct 8. Epub ahead of print.
doi: 10.1016/j.radonc.2011.07.016

PubMed Abstract
PMID: 21985948

UroToday.com Prostate Cancer Section